ThinkTrends Agentic AI Goes Live With the U.S. Food and Drug Administration’s Nationwide Adverse Event Monitoring System

ThinkTrends agentic Document AI platform plays a critical role in the new system by handling unstructured safety data intake across centers. From emailed forms to scanned PDFs and handwritten reports, the system automates the extraction, normalization, and regulatory conversion of safety data. Using advanced AI, reports are classified, coded, and converted into structured outputs that accelerate the agency’s ability to analyze and act on emerging safety concerns.

The agency estimates approximately six to seven million adverse event reports are processed annually across multiple databases. ThinkTrends agentic Document AI platform for pharmacovigilance intake played a key role in this modernization effort by automating the ingestion, classification, and normalization of large volumes of adverse event data across the agency’s multiple product centers. By consolidating these systems into a unified AI-enabled platform, the new AEM is expected to improve speed, accuracy, and accessibility.

“Modernizing adverse event monitoring at a national scale required consolidating multiple legacy systems, handling millions of safety reports, and delivering a reliable platform on an accelerated timeline,” said Jyotiska Biswas, CEO of ThinkTrends. “We are proud to support the FDA in deploying a system that strengthens real-time safety surveillance for regulators, researchers, and the public.”